About this trial
Metabolic flexibility is a process in which the body can switch energy substrates in different physiological states. This flexibility plays an important role in an individual's health because losing it increases the risk of obesity, metabolic syndrome, insulin resistance, and type 2 diabetes. Considering that humans spend most of their awakening hours in a postprandial (PP) state, an organism's metabolic flexibility (MF) to respond to a standardized meal's consumption would provide information on the individual's metabolic health. The PP response to glucose following an oral glucose tolerance test or consumption of a high-carbohydrate meal is well described; however, few studies assess the FM and PP metabolome using mixed meals with different macronutrients. The investigators address how metabolic flexibility and metabolome change after consuming standardized meals with different macronutrient ratios. Data collection includes clinical and diet information, indirect calorimetry, and capillary blood sampling during fasting and after consumption of standardized meals. Samples are collected weekly for one month. The data will determine the metabolic flexibility and metabolome after consuming standardized meals with different macronutrient ratios.
Eligibility criteria
Qualifiers
be over 18 years of age and under 30 years of age;
without active drug addictions: smoking, alcoholism, and/or drug addiction;
in female subjects: regular menstrual cycles;
give written consent for their inclusion in the study.
Disqualifiers
subjects with any pathology that requires medication or special treatment, such as type 2 diabetes mellitus, high blood pressure, dyslipidemia, polycystic ovary syn-drome, autoimmune, thyroid, kidney, neurological diseases, and cancer;
pregnant or lactating women;
subjects with problems with chewing, salivation, and swallowing.
subjects who only have samples (blood and calorimetry) from one study period (fasting or postprandial);
Trial design
Treatments tested in this trial
- High carbohydrate challenge
- High lipid challenge
- High proteinchallenge
Treatment groups
Locations
1Sponsors and collaborators
Instituto Nacional de Medicina Genomica
Lead sponsor
Universidad Nacional Autonoma de Mexico
Collaborator